Prognostic Correlation Between the Ratio of the Neutrophil Ratio to the Ratio of CD4+/CD8+ T Cells in Patients With Advanced Non-small Cell Lung Cancer NSCLC) Undergoing Immunotherapy Combined With Chemotherapy
Clinical trial NCT06954259 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06954259
- Sponsor
- Qiang Xu
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-01
- Primary completion
- 2024-06-30
- Enrollment
- 272
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.